The CREBBP and EP300 genes are recurrently mutated in FL and DLBCL, which may result in the reduced acetylation of BCL6 and associated increases in BCL6 activity (Pasqualucci et al., 2011a). This evidence concerns the gene EP300 and diffuse large B-cell lymphoma.